“DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY”, Int. Res. J. Pharm., vol. 17, no. 3, pp. 1–11, Mar. 2026, doi: 10.56802/e8qzhp89.